ACHFF (Arch Biopartners) Tariff Resilience Score: 6/10 (As of Jun. 30, 2026)


ACHFF Arch Biopartners Inc ACHFF
26 GF Score
Price $0.56
! 4 Warning Signs
View Full Analysis

What is Arch Biopartners Tariff Resilience Score?

Arch Biopartners ACHFF 26 Tariff Resilience Score is 6 as of Jun. 30, 2026. GuruFocus rates ACHFF with a GF Score™ of 26/100. The stock has 4 warning signs investors should review. Among 1,375 Biotechnology companies, Arch Biopartners ranks better than 76% on this metric.

Arch Biopartners has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Arch Biopartners has Biotech company with potential exposure to tariffs on imported research materials. However, it can mitigate risks through alternative suppliers and has some pricing power in niche markets.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Arch Biopartners might have Average Resilient.

Arch Biopartners  (OTCPK:ACHFF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Arch Biopartners Tariff Resilience Score Related Terms

ACHFF vs VRTX, REGN, ALNY: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Arch Biopartners's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Biopartners Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's Tariff Resilience Score falls into.


ACHFF
26GF Score
Arch Biopartners Inc ACHFF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Arch Biopartners (ACHFF) has a Tariff Resilience Score of 6 as of Jun. 30, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Arch Biopartners ranks #330 out of 1375 companies in the Biotechnology industry, placing it in the top 24%.
Is Arch Biopartners' Tariff Resilience Score too high?
Arch Biopartners' current Tariff Resilience Score is 6. The Biotechnology industry median Tariff Resilience Score is 4.00. Arch Biopartners' value of 6 is 50% above this industry median. Based on the distribution chart, Arch Biopartners ranks #330 out of 1375 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Arch Biopartners has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Arch Biopartners' Tariff Resilience Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Arch Biopartners ranks #330 out of 1375 companies for Tariff Resilience Score. This places Arch Biopartners in the top 24% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Arch Biopartners' value of 6 is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,375 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arch Biopartners's current Tariff Resilience Score of 6 is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arch Biopartners's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arch Biopartners stock overvalued right now?
Arch Biopartners (ACHFF) has a current Tariff Resilience Score of 6. The current Tariff Resilience Score is 6 and 50% above the Biotechnology industry median of 4.00. Arch Biopartners' overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Arch Biopartners (ACHFF), the current Tariff Resilience Score is 6 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Biopartners Business Description

Other Exchanges 8HA:GermanyARCH:Canada
Address 545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.
26GF Score

Get the complete analysis for ACHFF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.56
Price